Axon Neuroscience
PrivateLast Round
Grant
May 1, 2016
Total Funding Raised
$1.08M
Company Overview
Axon Neuroscience is a biotechnology company that develops disease-modifying immunotherapeutics designed to treat Alzheimer's disease and other tauopathies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axon Neuroscience Comparables
Compare Axon Neuroscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AC Immune SA | 80% | |
| Vaxxinity, Inc. | 77% | |
| Nuravax | 77% | |
Axon Neuroscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2016 | ||||
| Grant | Nov 10, 2015 | ||||
| Grant | Nov 10, 2015 | ||||
| Grant | Jun 1, 2012 | ||||
| Grant | Apr 1, 2011 | ||||
Grant | Jan 1, 2011 |
Axon Neuroscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| Directorate-General for Health and Food Safety | Grant |
| International Centre for Genetic Engineering and Biotechnology | Grant |
| EU Joint Programme – Neurodegenerative Disease Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2016
$490K grant received from Horizon 2020.
- Nov 10, 2015
$120K grant received from Marie Skłodowska-Curie Actions.
Axon Neuroscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Axon Neuroscience's valuation, stock price, and market status.